ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL.

Babafemi O Taiwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.